XML 11 R2.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Current assets    
Cash and cash equivalents $ 124,782 $ 60,529
Available-for-sale securities - current 158,973 0
Accounts receivable, net 25,642 8,227
Inventories, net 11,615 8,293
Prepaid expenses and other current assets 11,606 3,309
Total current assets 332,618 80,358
Property and equipment, net 2,039 753
Available-for-sale securities - non-current 102,878 0
Internally developed software, net 12,475 7,416
Other non-current assets 2,294 1,082
Total assets 452,304 89,609
Current liabilities    
Accounts payable 6,229 3,732
Accrued expenses 24,184 5,781
Deferred revenue—current 6,016 2,344
Other current liabilities 4,342 0
Total current liabilities 40,771 11,857
Deferred revenue—non-current 24,190 13,178
Term loan, net 0 5,481
Convertible notes, net 0 51,714
Warrant liability 9,787 0
Other non-current liabilities 0 1,051
Total liabilities 74,748 83,281
Commitments and contingencies (see Note 11)
Redeemable convertible preferred stock, carrying value [1] 0 160,605
Stockholders’ equity (deficit)    
Common stock [1] 25 0
Additional paid-in capital 706,713 7,901
Accumulated other comprehensive income (loss) (676) 9
Accumulated deficit (328,506) (162,187)
Total stockholders’ equity (deficit) 377,556 (154,277)
Total liabilities, redeemable convertible preferred stock and stockholders’ equity (deficit) $ 452,304 $ 89,609
[1] Shares outstanding for all periods reflect the adjustment for the Exchange Ratio as a result of the Business Combination. Shares issued and outstanding as of December 31, 2021 excludes 738,000 shares subject to vesting requirements. See Note 1, Description of Business.